146 related articles for article (PubMed ID: 9616091)
1. [Mefloquine: neuropsychiatric adverse effects are often severe and persistent long after withdrawal of the drug].
Jensen JJ
Ugeskr Laeger; 1998 Apr; 160(16):2413. PubMed ID: 9616091
[No Abstract] [Full Text] [Related]
2. [Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
Bygbjerg IC; Rønn AM
Ugeskr Laeger; 1999 Mar; 161(10):1422-3. PubMed ID: 10085752
[TBL] [Abstract][Full Text] [Related]
3. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine.
Clattenburg RN; Donnelly CL
J Am Acad Child Adolesc Psychiatry; 1997 Nov; 36(11):1606-8. PubMed ID: 9394947
[TBL] [Abstract][Full Text] [Related]
4. [Neuropsychiatric symptoms caused by mefloquine (report of several cases)].
Murai Z; Baran B; Tolna J; Szily E; Gazdag G
Orv Hetil; 2005 Jan; 146(3):133-6. PubMed ID: 15693445
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric events and travel: do antimalarials play a role?
Schlagenhauf P; Steffen R
J Travel Med; 2000; 7(5):225-6. PubMed ID: 11231204
[No Abstract] [Full Text] [Related]
6. Malaria, mefloquine and the mind.
Ingram RJ; Ellis-Pegler RB
N Z Med J; 1997 Apr; 110(1042):137-8. PubMed ID: 9152353
[No Abstract] [Full Text] [Related]
7. Mefloquine-induced pneumonitis.
Soentjens P; Delanote M; Van Gompel A
J Travel Med; 2006; 13(3):172-4. PubMed ID: 16706949
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and neuropsychiatric side effects of mefloquine.
Javorsky DJ; Tremont G; Keitner GI; Parmentier AH
J Neuropsychiatry Clin Neurosci; 2001; 13(2):302. PubMed ID: 11449039
[No Abstract] [Full Text] [Related]
9. Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study.
Rønn AM; Rønne-Rasmussen J; Gøtzsche PC; Bygbjerg IC
Trop Med Int Health; 1998 Feb; 3(2):83-8. PubMed ID: 9537268
[TBL] [Abstract][Full Text] [Related]
10. Mefloquine use and hospitalizations among US service members, 2002-2004.
Wells TS; Smith TC; Smith B; Wang LZ; Hansen CJ; Reed RJ; Goldfinger WE; Corbeil TE; Spooner CN; Ryan MA
Am J Trop Med Hyg; 2006 May; 74(5):744-9. PubMed ID: 16687673
[TBL] [Abstract][Full Text] [Related]
11. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.
van Riemsdijk MM; Sturkenboom MC; Ditters JM; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
Br J Clin Pharmacol; 2004 Apr; 57(4):506-12. PubMed ID: 15025750
[TBL] [Abstract][Full Text] [Related]
12. Neuropsychiatric events during prophylactic use of mefloquine before travelling.
van Riemsdijk MM; Ditters JM; Sturkenboom MC; Tulen JH; Ligthelm RJ; Overbosch D; Stricker BH
Eur J Clin Pharmacol; 2002 Sep; 58(6):441-5. PubMed ID: 12242605
[TBL] [Abstract][Full Text] [Related]
13. Mefloquine and scuba diving.
Wright D
N Z Med J; 1995 Dec; 108(1013):514. PubMed ID: 8532239
[No Abstract] [Full Text] [Related]
14. Severe psychiatric side effects observed during prophylaxis and treatment with mefloquine.
Hennequin C; Bourée P; Bazin N; Bisaro F; Feline A
Arch Intern Med; 1994 Oct; 154(20):2360-2. PubMed ID: 7944858
[TBL] [Abstract][Full Text] [Related]
15. Paranoid psychosis related to mefloquine antimalarial prophylaxis.
Fuller SJ; Naraqi S; Gilessi G
P N G Med J; 2002; 45(3-4):219-21. PubMed ID: 12968793
[TBL] [Abstract][Full Text] [Related]
16. MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Aarnoudse AL; van Schaik RH; Dieleman J; Molokhia M; van Riemsdijk MM; Ligthelm RJ; Overbosch D; van der Heiden IP; Stricker BH
Clin Pharmacol Ther; 2006 Oct; 80(4):367-74. PubMed ID: 17015054
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous reports of psychiatric adverse effects to mefloquine in the Netherlands.
van Riemsdijk MM; van der Klauw MM; Pepplinkhuizen L; Stricker BH
Br J Clin Pharmacol; 1997 Jul; 44(1):105-6. PubMed ID: 9241106
[No Abstract] [Full Text] [Related]
18. [Neuropsychiatric side effects of malarial prophylaxis with mefloquine (Lariam)].
Minei-Rachmilewitz T
Harefuah; 1999 Jul; 137(1-2):25-7, 87. PubMed ID: 10959270
[TBL] [Abstract][Full Text] [Related]
19. [Convulsions during prophylactic use of mefloquine].
Heeringa M; Kuster JA; Meyboom RH; Bouvy M
Ned Tijdschr Geneeskd; 1998 Nov; 142(45):2477-80. PubMed ID: 10028330
[TBL] [Abstract][Full Text] [Related]
20. Acute and long-term psychiatric side effects of mefloquine: a follow-up on Danish adverse event reports.
Ringqvist Å; Bech P; Glenthøj B; Petersen E
Travel Med Infect Dis; 2015; 13(1):80-8. PubMed ID: 25435322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
